Mutant SOD1G93A microglia are more neurotoxic relative to wild‐type microglia

Onset and Progression in Inherited ALS Determined by Motor Neurons and Microglia

Boillée, S., Yamanaka, K., Lobsiger, C. S., Copeland, N. G., Jenkins, N. A., Kassiotis, G., Kollias, G., & Cleveland, D. W. (2006) · Science · doi:10.1126/science.1123511 · Cited by 1,623 · see citing works

Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities

McKercher, S. R., Torbett, B. E., Anderson, K. L., Henkel, G. W., Vestal, D. J., Baribault, H., Klemsz, M., Feeney, A. J., Wu, G. E., Paige, C. J., et al. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00949.x · Cited by 1,130 · see citing works

Wild-Type Nonneuronal Cells Extend Survival of SOD1 Mutant Motor Neurons in ALS Mice

Clement, A. M., Nguyen, M. D., Roberts, E. A., Garcia, M. L., Boillée, S., Rule, M., McMahon, A. P., Doucette, W. T., Siwek, D. F., Ferrante, R. J., et al. (2003) · Science · doi:10.1126/science.1086071 · Cited by 1,101 · see citing works

Retrograde Viral Delivery of IGF-1 Prolongs Survival in a Mouse ALS Model

Kaspar, B. K., Lladó, J., Sherkat, N., Rothstein, J. D., & Gage, F. H. (2003) · Science · doi:10.1126/science.1086137 · Cited by 872 · see citing works

Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis

Beers, D. R., Henkel, J. S., Xiao, Q., Zhao, W., Wang, J., Yen, A. A., Siklos, L., McKercher, S. R., & Appel, S. H. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607423103 · Cited by 733 · see citing works

SOCS-1 Participates in Negative Regulation of LPS Responses

Nakagawa, R., Naka, T., Tsutsui, H., Fujimoto, M., Kimura, A., Abe, T., Seki, E., Sato, S., Takeuchi, O., Takeda, K., et al. (2002) · Immunity · doi:10.1016/s1074-7613(02)00449-1 · Cited by 638 · see citing works

Presence of dendritic cells, MCP‐1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue

Henkel-Tigges, J., Engelhardt, J., Siklós, L., Simpson, E. P., Kim, S. H., Pan, T., Goodman, J. C., Siddique, T., Beers, D. R., & Appel, S. H. (2003) · Annals of Neurology · doi:10.1002/ana.10805 · Cited by 554 · see citing works

Neuron-Specific Expression of Mutant Superoxide Dismutase 1 in Transgenic Mice Does Not Lead to Motor Impairment

Pramatarova, A., Laganière, J., Roussel, J., Brisebois, K., & Rouleau, G. A. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-10-03369.2001 · Cited by 482 · see citing works

Immune reactivity in a mouse model of familial ALS correlates with disease progression

Alexianu, M. E., Kozovska, M., & Appel, S. H. (2001) · Neurology · doi:10.1212/wnl.57.7.1282 · Cited by 438 · see citing works

Conversion to the amyotrophic lateral sclerosis phenotype is associated with intermolecular linked insoluble aggregates of SOD1 in mitochondria

Deng, H., Shi, Y., Furukawa, Y., Zhai, H., Fu, R., Liu, E., Gorrie, G., Khan, M. S., Hung, W.-Y., Bigio, E. H., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602046103 · Cited by 432 · see citing works

Motoneuron Death Triggered by a Specific Pathway Downstream of Fas

Raoul, C., Estévez, Á. G., Nishimune, H., Cleveland, D. W., deLapeyrière, O., Henderson, C. E., Haase, G., & Pettmann, B. (2002) · Neuron · doi:10.1016/s0896-6273(02)00905-4 · Cited by 432 · see citing works

Accumulation of SOD1 Mutants in Postnatal Motoneurons Does Not Cause Motoneuron Pathology or Motoneuron Disease

Lino, M. M., Schneider, C., & Caroni, P. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-12-04825.2002 · Cited by 424 · see citing works

Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis

Urushitani, M., Sik, A., Sakurai, T., Nukina, N., Takahashi, R., & Julien, J.-P. (2006) · Nature Neuroscience · doi:10.1038/nn1603 · Cited by 419 · see citing works

Activation of microglia by aggregated β-amyloid or lipopolysaccharide impairs MHC-II expression and renders them cytotoxic whereas IFN-γ and IL-4 render them protective

Butovsky, O., Talpalar, A. E., Ben‐Yaakov, K., & Schwartz, M. (2005) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2005.03.005 · Cited by 368 · see citing works

Human Cu/Zn Superoxide Dismutase (SOD1) Overexpression in Mice Causes Mitochondrial Vacuolization, Axonal Degeneration, and Premature Motoneuron Death and Accelerates Motoneuron Disease in Mice Expressing a Familial Amyotrophic Lateral Sclerosis Mutant SOD1

Jaarsma, D., Haasdijk, E. D., Grashorn, J., Hawkins, R. K., van Duijn, W., Verspaget, H. W., London, J., & Holstege, J. C. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.2000.0299 · Cited by 351 · see citing works

Nitric Oxide and Superoxide Contribute to Motor Neuron Apoptosis Induced by Trophic Factor Deprivation

Estévez, Á. G., Spear, N., Manuel, S. M., Radí, R., Henderson, C. E., Barbeito, L., & Beckman, J. S. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-03-00923.1998 · Cited by 344 · see citing works

Lymphocytic Infiltrates in the Spinal Cord in Amyotrophic Lateral Sclerosis

Engelhardt, J. I., Tajti, J., & Appel, S. H. (1993) · Archives of Neurology · doi:10.1001/archneur.1993.00540010026013 · Cited by 318 · see citing works

Microglial Activation and Dopaminergic Cell Injury: AnIn VitroModel Relevant to Parkinson's Disease

Le, W. D., Rowe, D. B., Xie, W., Ortiz, I., He, Y., & Appel, S. H. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-21-08447.2001 · Cited by 274 · see citing works

Peroxynitrite Mediates Neurotoxicity of Amyloid β-Peptide _1–42 - and Lipopolysaccharide-Activated Microglia

Xie, Z., Wei, M., Morgan, T. E., Fabrizio, P., Han, D., Finch, C. E., & Longo, V. D. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03484.2002 · Cited by 272 · see citing works

Motor neuron degeneration in amyotrophic lateral sclerosis mutant superoxide dismutase‐1 transgenic mice: Mechanisms of mitochondriopathy and cell death

Martin, L. J., Liu, Z., Chen, K. Y., Price, A. C., Pan, Y. H., Swaby, J. A., & Golden, W. C. (2006) · The Journal of Comparative Neurology · doi:10.1002/cne.21160 · Cited by 270 · see citing works

Involvement of Suppressor of Cytokine Signaling-3 as a Mediator of the Inhibitory Effects of IL-10 on Lipopolysaccharide-Induced Macrophage Activation

Berlato, C., Cassatella, M. A., Kinjyo, I., Gatto, L., Yoshimura, A., & Bazzoni, F. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.12.6404 · Cited by 267 · see citing works

Activation of microglia by secreted amyloid precursor protein evokes release of glutamate by cystine exchange and attenuates synaptic function

Barger, S. W., & Basile, A. S. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00075.x · Cited by 264 · see citing works

Synergistic Dopaminergic Neurotoxicity of the Pesticide Rotenone and Inflammogen Lipopolysaccharide: Relevance to the Etiology of Parkinson's Disease

Gao, H., Hong, J., Zhang, W., & Liu, B. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-04-01228.2003 · Cited by 251 · see citing works

Inducible Nitric Oxide Synthase Up‐Regulation in a Transgenic Mouse Model of Familial Amyotrophic Lateral Sclerosis

Almer, G., Vukosavić, S., Romero, N. B., & Przedborski, S. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0722415.x · Cited by 231 · see citing works

Brain Injury after Perinatal Hypoxia-Ischemia Is Exacerbated in Copper/Zinc Superoxide Dismutase Transgenic Mice

Ditelberg, J. S., Sheldon, R. A., Epstein, C. J., & Ferriero, D. M. (1996) · Pediatric Research · doi:10.1203/00006450-199602000-00003 · Cited by 193 · see citing works

Copper/zinc superoxide dismutase transgenic brain accumulates hydrogen peroxide after perinatal hypoxia ischemia

Fullerton, H. J., Ditelberg, J. S., Chen, S. F., Sarco, D. P., Chan, P. H., Epstein, C. J., & Ferriero, D. M. (1998) · Annals of Neurology · doi:10.1002/ana.410440311 · Cited by 183 · see citing works

The chemokine MCP-1 and the dendritic and myeloid cells it attracts are increased in the mSOD1 mouse model of ALS

Henkel-Tigges, J., Beers, D. R., Siklós, L., & Appel, S. H. (2005) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2005.10.016 · Cited by 181 · see citing works

Microglia release activators of neuronal proliferation mediated by activation of mitogen‐activated protein kinase, phosphatidylinositol‐3‐kinase/Akt and delta–Notch signalling cascades

Morgan, S. C., Taylor, D. L., & Pocock, J. M. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02461.x · Cited by 175 · see citing works

Protective effects of an anti‐inflammatory cytokine, interleukin‐4, on motoneuron toxicity induced by activated microglia

Zhao, W., Xie, W., Xiao, Q., Beers, D. R., & Appel, S. H. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04172.x · Cited by 172 · see citing works

Gene expression patterns for GDNF and its receptors in the human putamen affected by Parkinson's disease: A real-time PCR study

Bäckman, C. M., Shan, L., Zhang, Y. J., Hoffer, B. J., Leonard, S. S., Troncoso, J. C., Vonsatel, P., & Tomac, A. C. (2006) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2006.03.013 · Cited by 170 · see citing works

Activated Microglia Initiate Motor Neuron Injury by a Nitric Oxide and Glutamate-Mediated Mechanism

Zhao, W., Xie, W., Le, W., Beers, D. R., He, Y., Henkel-Tigges, J., Simpson, E. P., Yen, A. A., Xiao, Q., & Appel, S. H. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.9.964 · Cited by 169 · see citing works

Parvalbumin overexpression alters immune‐mediated increases in intracellular calcium, and delays disease onset in a transgenic model of familial amyotrophic lateral sclerosis

Beers, D. R., Ho, B., Siklós, L., Alexianu, M. E., Mosier, D. R., Mohamed, A. H., Otsuka, Y., Kozovska, M. E., McAlhany, R. E., Smith, R. G., et al. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00582.x · Cited by 166 · see citing works

IGF-I prevents glutamate-induced motor neuron programmed cell death

Vincent, A. M., Mobley, B. C., Hiller, A., & Feldman, E. L. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.03.001 · Cited by 148 · see citing works

Oxidative stress and neuroinflammation in Alzheimer's disease and amyotrophic lateral sclerosis: Common links and potential therapeutic targets

Mhatre, M., Floyd, R. A., & Hensley, K. (2004) · Journal of Alzheimer s Disease · doi:10.3233/jad-2004-6206 · Cited by 147 · see citing works

Increased cytotoxic potential of microglia from ALS‐transgenic mice

Weydt, P., Yuen, E., Ransom, B. R., & Möller, T. (2004) · Glia · doi:10.1002/glia.20062 · Cited by 147 · see citing works

Chronic activation in presymptomatic amyotrophic lateral sclerosis (ALS) mice of a feedback loop involving Fas, Daxx, and FasL

Raoul, C., Buhler, E., Sadeghi, C., Jacquier, A., Aebischer, P., Pettmann, B., Henderson, C. E., & Haase, G. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508774103 · Cited by 116 · see citing works

Visualization of mitotic radial glial lineage cells in the developing rat brain by Cdc2 kinase-phosphorylated vimentin

Kamei, Y., Inagaki, N., Nishizawa, M., Tsutsumi, O., Taketani, Y., & Inagaki, M. (1998) · Glia · doi:10.1002/(sici)1098-1136(199807)23:3 · Cited by 114 · see citing works

Neural cell culture: a practical approach

Cohen, J., & Wilkin, G. P. (1995) · Cited by 109 · see citing works

Activated microglia (BV-2) facilitation of TNF-α-mediated motor neuron death in vitro

He, B. P., Wen, W., & Strong, M. J. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00141-8 · Cited by 98 · see citing works

Therapeutic benefit of intrathecal injection of insulin-like growth factor-1 in a mouse model of Amyotrophic Lateral Sclerosis

Nagano, I., Ilieva, H. S., Shiote, M., Murakami, T., Yokoyama, M., Shoji, M., & Abe, K. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.04.011 · Cited by 96 · see citing works

The peripheral insulin-like growth factor system in amyotrophic lateral sclerosis and in multiple sclerosis

Torres‐Alemán, I., Barrios, V., & Berciano, J. (1998) · Neurology · doi:10.1212/wnl.50.3.772 · Cited by 91 · see citing works

Microglial signalling cascades in neurodegenerative disease

Pocock, J. M., & Liddle, A. C. (2001) · Progress in brain research · doi:10.1016/s0079-6123(01)32103-9 · Cited by 90 · see citing works

Free insulin-like growth factor (IGF)-I and IGF binding proteins 2, 5, and 6 in spinal motor neurons in amyotrophic lateral sclerosis

Wilczak, N., de Vos, R. A., & Keyser, J. D. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12828-0 · Cited by 88 · see citing works

Lack of involvement of neuronal nitric oxide synthase in the pathogenesis of a transgenic mouse model of familial amyotrophic lateral sclerosis

Facchinetti, F., Sasaki, M., Cutting, F. B., Macdonald, J. E., Reif, D. W., Beal, M. F., Huang, P. L., Dawson, T. M., Gurney, M. E., Dawson, V. L., et al. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00492-8 · Cited by 85 · see citing works

Adverse Effect of a Presenilin-1 Mutation in Microglia Results in Enhanced Nitric Oxide and Inflammatory Cytokine Responses to Immune Challenge in the Brain

Mattson, M. P., Lee, J., & Chan, S. L. (2002) · NeuroMolecular Medicine · doi:10.1385/nmm:2:1:29 · Cited by 83 · see citing works

Survival in a transgenic model of fals is independent of inos expression

Son, M., Fathallah‐Shaykh, H. M., & Elliott, J. L. (2001) · Annals of Neurology · doi:10.1002/ana.1104 · Cited by 30 · see citing works

Prevention by insulin-like growth factor-I and riluzole in motor neuron death after neonatal axotomy

Iwasaki, Y., & Ikeda, K. (1999) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(99)00238-5 · Cited by 20 · see citing works

Hippocampal mossy fiber changes in mice transgenic for the human copper-zinc superoxide dismutase gene

Barkats, M., Bertholet, J.-Y., Venault, P., Ceballos-Picot, I., Nicole, A., Phillips, J. R. P., Moutier, R., Roubertoux, P. L., Sinet, P., & Cohen‐Salmon, C. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90908-4 · Cited by 17 · see citing works

Inflammatory Neurodegeneration Mediated by Nitric Oxide from Activated Glia-Inhibiting Neuronal Respiration, Causing Glutamate Release and Excitotoxicity

Bal-Price, A., & Brown, G. C. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-17-06480.2001

Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases

Tang, Y., & Le, W. (2016) · Molecular Neurobiology · doi:10.1007/s12035-014-9070-5 · Cited by 2,190 · see citing works

Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets

Gao, C., Jiang, J., Tan, Y., & Chen, S. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01588-0 · Cited by 1,616 · see citing works

A Neurodegeneration-Specific Gene-Expression Signature of Acutely Isolated Microglia from an Amyotrophic Lateral Sclerosis Mouse Model

Chiu, I. M., Morimoto, E. T. A., Goodarzi, H., Liao, J. T., O’Keeffe, S., Phatnani, H. P., Muratet, M., Carroll, M. C., Levy, S., Tavazoie, S., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.06.018 · Cited by 651 · see citing works

Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease

Philips, T., & Robberecht, W. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70015-1 · Cited by 646 · see citing works

Microglia Induce Motor Neuron Death via the Classical NF-κB Pathway in Amyotrophic Lateral Sclerosis

Frakes, A. E., Ferraiuolo, L., Haidet-Phillips, A. M., Schmelzer, L., Braun, L., Miranda, C. J., Ladner, K. J., Bevan, A. K., Foust, K. D., Godbout, J. P., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.01.013 · Cited by 638 · see citing works

Transformation from a neuroprotective to a neurotoxic microglial phenotype in a mouse model of ALS

Liao, B., Zhao, W., Beers, D. R., Henkel-Tigges, J., & Appel, S. H. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.06.011 · Cited by 438 · see citing works

Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis

Beers, D. R., Henkel-Tigges, J., Zhao, W., Wang, J., Huang, A., Wen, S., Liao, B., & Appel, S. H. (2011) · Brain · doi:10.1093/brain/awr074 · Cited by 427 · see citing works

Immune dysregulation in amyotrophic lateral sclerosis: mechanisms and emerging therapies

Beers, D. R., & Appel, S. H. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30394-6 · Cited by 387 · see citing works

T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS

Chiu, I., Chen, A., Zheng, Y., Kosaras, B., Tsiftsoglou, S., Vartanian, T., Brown, R. H., & Carroll, M. (2008) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.0804610105 · Cited by 374 · see citing works

Microglia in ALS: The Good, The Bad, and The Resting

Henkel, J. S., Beers, D. R., Zhao, W., & Appel, S. H. (2009) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-009-9171-5 · Cited by 353 · see citing works

The resolution of neuroinflammation in neurodegeneration: leukocyte recruitment via the choroid plexus

Schwartz, M., & Baruch, K. (2014) · The EMBO Journal · doi:10.1002/embj.201386609 · Cited by 349 · see citing works

Untitled work

(2018) · doi:10.1007/s00401-018-1933-9

Emerging mechanisms of molecular pathology in ALS

Peters, O. M., Ghasemi, M., & Brown, R. H. (2015) · Journal of Clinical Investigation · doi:10.1172/jci71601 · Cited by 319 · see citing works

Skeletal muscle-restricted expression of human SOD1 causes motor neuron degeneration in transgenic mice

Wong, M., & Martin, L. J. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq106 · Cited by 318 · see citing works

Immune-mediated Mechanisms in the Pathoprogression of Amyotrophic Lateral Sclerosis

Zhao, W., Beers, D. R., & Appel, S. H. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9489-x · Cited by 298 · see citing works

Extracellular mutant SOD1 induces microglial‐mediated motoneuron injury

Zhao, W., Beers, D. R., Henkel, J. S., Zhang, W., Urushitani, M., Julien, J., & Appel, S. H. (2010) · Glia · doi:10.1002/glia.20919 · Cited by 288 · see citing works

Microglial Activation Correlates with Disease Progression and Upper Motor Neuron Clinical Symptoms in Amyotrophic Lateral Sclerosis

Brettschneider, J., Toledo, J. B., Van Deerlin, V. M., Elman, L., McCluskey, L., Lee, V. M.-Y., & Trojanowski, J. Q. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039216 · Cited by 268 · see citing works

Human conditions of insulin-like growth factor-I (IGF-I) deficiency

Puche, J. E., & Castilla‐Cortázar, I. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-224 · Cited by 271 · see citing works

T cell-microglial dialogue in Parkinson's disease and amyotrophic lateral sclerosis: are we listening?

Appel, S. H., Beers, D. R., & Henkel, J. S. (2010) · Trends in Immunology · doi:10.1016/j.it.2009.09.003 · Cited by 256 · see citing works

The Dual Role of Microglia in ALS: Mechanisms and Therapeutic Approaches

Geloso, M. C., Corvino, V., Marchese, E., Serrano, A., Michetti, F., & D’Ambrosi, N. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00242 · Cited by 239 · see citing works

TDP-43 activates microglia through NF-κB and NLRP3 inflammasome

Zhao, W., Beers, D. R., Bell, S., Wang, J., Wen, S., Baloh, R. H., & Appel, S. H. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.07.019 · Cited by 241 · see citing works

Diversity and plasticity of microglial cells in psychiatric and neurological disorders

Nakagawa, Y., & Chiba, K. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.06.010 · Cited by 208 · see citing works

Genetic Correction of Human Induced Pluripotent Stem Cells from Patients with Spinal Muscular Atrophy

Corti, S. P., Nizzardo, M., Simone, C., Falcone, M., Nardini, M., Ronchi, D., Donadoni, C., Salani, S., Riboldi, G. M., Magri, F., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004108 · Cited by 207 · see citing works

Pharmacological Modulation of Functional Phenotypes of Microglia in Neurodegenerative Diseases

Song, G. J., & Suk, K. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00139 · Cited by 199 · see citing works

Adaptive Immune Neuroprotection in G93A-SOD1 Amyotrophic Lateral Sclerosis Mice

Banerjee, R., Mosley, R. L., Reynolds, A. D., Dhar, A., Jackson-Lewis, V. R., Gordon, P. H., Przedborski, S., & Gendelman, H. E. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002740 · Cited by 198 · see citing works

Neuroinflammation modulates distinct regional and temporal clinical responses in ALS mice

Beers, D. R., Zhao, W., Liao, B., Kano, O., Wang, J., Huang, A., Appel, S. H., & Henkel-Tigges, J. (2010) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2010.12.008 · Cited by 197 · see citing works

Nitrated α-Synuclein-Induced Alterations in Microglial Immunity Are Regulated by CD4+ T Cell Subsets

Reynolds, A. D., Stone, D. K., Mosley, R. L., & Gendelman, H. E. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803982 · Cited by 197 · see citing works

Microglia and C9orf72 in neuroinflammation and ALS and frontotemporal dementia

Lall, D., & Baloh, R. H. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90607 · Cited by 175 · see citing works

The microglial component of amyotrophic lateral sclerosis

Clarke, B. E., & Patani, R. (2020) · Brain · doi:10.1093/brain/awaa309 · Cited by 164 · see citing works

Delivery of AAV-IGF-1 to the CNS Extends Survival in ALS Mice Through Modification of Aberrant Glial Cell Activity

Dodge, J. C., Haidet, A. M., Yang, W., Passini, M. A., Hester, M. E., Clarke, J., Roskelley, E. M., Treleaven, C. M., Rizo, L., Martin, H. L., et al. (2008) · Molecular Therapy · doi:10.1038/mt.2008.60 · Cited by 160 · see citing works

Ablation of Proliferating Microglia Does Not Affect Motor Neuron Degeneration in Amyotrophic Lateral Sclerosis Caused by Mutant Superoxide Dismutase

Gowing, G., Philips, T., Wijmeersch, B. V., Audet, J., Dewil, M., Bosch, L. V. D., Billiau, A., Robberecht, W., & Julien, J. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.3494-08.2008 · Cited by 150 · see citing works

Non-neuronal cells in amyotrophic lateral sclerosis — from pathogenesis to biomarkers

Vahsen, B. F., Gray, E., Thompson, A. G., Ansorge, O., Anthony, D. C., Cowley, S. A., Talbot, K., & Turner, M. R. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-021-00487-8 · Cited by 147 · see citing works

Oxidized/misfolded superoxide dismutase‐1: the cause of all amyotrophic lateral sclerosis?

Kabashi, E., Valdmanis, P. N., Dion, P. A., & Rouleau, G. A. (2007) · Annals of Neurology · doi:10.1002/ana.21319 · Cited by 140 · see citing works

Regulatory T lymphocytes from ALS mice suppress microglia and effector T lymphocytes through different cytokine-mediated mechanisms

Zhao, W., Beers, D. R., Liao, B., Henkel-Tigges, J., & Appel, S. H. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.07.008 · Cited by 137 · see citing works

The role of microglia in human disease: therapeutic tool or target?

Cartier, N., Lewis, C. B., Zhang, R., & Rossi, F. M. V. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1330-y · Cited by 135 · see citing works

Non-cell-autonomous pathogenic mechanisms in amyotrophic lateral sclerosis

Harten, A. C. M. V., Phatnani, H. P., & Przedborski, S. (2021) · Trends in Neurosciences · doi:10.1016/j.tins.2021.04.008 · Cited by 126 · see citing works

Neurotheranostics as Personalized Medicines

Kevadiya, B. D., Ottemann, B. M., Thomas, M. B., Mukadam, I., Nigam, S., McMillan, J., Gorantla, S., Bronich, T. K., Edagwa, B., & Gendelman, H. E. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.10.011 · Cited by 124 · see citing works

Differential contribution of microglia and monocytes in neurodegenerative diseases

Baufeld, C., O'Loughlin, E. K., Calcagno, N., Madore, C., & Butovsky, O. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1795-7 · Cited by 123 · see citing works

The adult human brain in preclinical drug development

Dragunow, M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2617 · Cited by 120 · see citing works

IL-10 Controls Early Microglial Phenotypes and Disease Onset in ALS Caused by Misfolded Superoxide Dismutase 1

Gravel, M., Béland, L.-C., Soucy, G., Abdelhamid, E., Rahimian, R., Gravel, C., & Kriz, J. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.0854-15.2016 · Cited by 117 · see citing works

Neurotrophic growth factors for the treatment of amyotrophic lateral sclerosis: where do we stand ?

Henriques (2010) · Frontiers in Neuroscience · doi:10.3389/fnins.2010.00032 · Cited by 115 · see citing works

Nitric Oxide/Nitric Oxide Synthase System in the Pathogenesis of Neurodegenerative Disorders—An Overview

Iova, O.-M., Marin, G.-E., Lazar, I., Stănescu, I., Dogaru, G., Nicula, C. A., & Bulboacă, A. E. (2023) · Antioxidants · doi:10.3390/antiox12030753 · Cited by 120 · see citing works

Glial Cells in Amyotrophic Lateral Sclerosis

Lasiene, J., & Yamanaka, K. (2011) · Neurology Research International · doi:10.1155/2011/718987 · Cited by 110 · see citing works

Chimerization of astroglial population in the lumbar spinal cord after mesenchymal stem cell transplantation prolongs survival in a rat model of amyotrophic lateral sclerosis

Boucherie, C., Schäfer, S., Lavand'homme, P. M., Maloteaux, J., & Hermans, E. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22038 · Cited by 100 · see citing works

The microbiota–microglia axis in central nervous system disorders

Mossad, O., & Erny, D. (2020) · Brain Pathology · doi:10.1111/bpa.12908 · Cited by 98 · see citing works

The cannabinoid system and microglia in health and disease

Duffy, S. S., Hayes, J. P., Fiore, N. T., & Moalem‐Taylor, G. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108555 · Cited by 96 · see citing works

Optineurin in amyotrophic lateral sclerosis: Multifunctional adaptor protein at the crossroads of different neuroprotective mechanisms

Markovinović, A., Cimbro, R., Ljutić, T., Križ, J., Rogelj, B., & Munitić, I. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.04.005 · Cited by 94 · see citing works

Temporal evolution of the microbiome, immune system, and epigenome with disease progression in ALS mice

Figueroa-Romero, C., Guo, K., Murdock, B. J., Paez-Colasante, X., Bassis, C. M., Mikhail, K. A., Raue, K. D., Evans, M. C., Taubman, G. F., McDermott, A. J., et al. (2019) · Disease Models & Mechanisms · doi:10.1242/dmm.041947 · Cited by 94 · see citing works

Neuroinflammation in motor neuron disease

Endo, F., Komine, O., & Yamanaka, K. (2016) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12309 · Cited by 93 · see citing works

Abnormal Changes in NKT Cells, the IGF-1 Axis, and Liver Pathology in an Animal Model of ALS

Finkelstein, A., Kunis, G., Seksenyan, A., Ronen, A., Berkutzki, T., Azoulay, D., Koronyo‐Hamaoui, M., & Schwartz, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022374 · Cited by 89 · see citing works

The role of CNS glia in preserving axon function

Edgar, J. M., & Nave, K. (2009) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2009.08.003 · Cited by 88 · see citing works

Neuroinflammation in motor neuron disease.

Komine, O., & Yamanaka, K. (2015) · Europe PMC (PubMed Central) · doi:10.18999/nagjms.77.4.537 · Cited by 87 · see citing works

Studying neurodegenerative diseases in culture models

Schlachetzki, J. C. M., Saliba, S. W., & de Oliveira, A. C. P. (2013) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2013-1159 · Cited by 80 · see citing works

TGF-β1 Neuroprotection via Inhibition of Microglial Activation in a Rat Model of Parkinson’s Disease

Chen, X., Liu, Z., Cao, B., Qiu, Y., & Peng, Y.-P. (2017) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-017-9732-y · Cited by 77 · see citing works

The Neuroinflammatory Response in ALS: The Roles of Microglia and T Cells

Lewis, C.-A., Manning, J., Rossi, F., & Krieger, C. (2012) · Neurology Research International · doi:10.1155/2012/803701 · Cited by 76 · see citing works

The dual roles of immunity in ALS: Injury overrides protection

Murdock, B. J., Bender, D. E., Segal, B. M., & Feldman, E. L. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.02.017 · Cited by 73 · see citing works

Peripheral and Central Nervous System Immune Response Crosstalk in Amyotrophic Lateral Sclerosis

Liu, Z., Cheng, X., Zhong, S., Zhang, X., Liu, C., Liu, F., & Zhao, C. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00575 · Cited by 66 · see citing works

Hepatocyte growth factor (HGF) attenuates gliosis and motoneuronal degeneration in the brainstem motor nuclei of a transgenic mouse model of ALS

Kadoyama, K., Funakoshi, H., Ohya, W., & Nakamura, T. (2007) · Neuroscience Research · doi:10.1016/j.neures.2007.08.017 · Cited by 65 · see citing works

In Vivo Imaging Reveals Distinct Inflammatory Activity of CNS Microglia versus PNS Macrophages in a Mouse Model for ALS

Dibaj, P., Steffens, H., Zschüntzsch, J., Nadrigny, F., Schomburg, E. D., Kirchhoff, F., & Neusch, C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017910 · Cited by 63 · see citing works

Insulin-like growth factor-I for the treatment of amyotrophic lateral sclerosis

Sakowski, S. A., Schuyler, A. D., & Feldman, E. L. (2008) · Amyotrophic Lateral Sclerosis · doi:10.1080/17482960802160370 · Cited by 64 · see citing works

Inhibitory Synaptic Regulation of Motoneurons: A New Target of Disease Mechanisms in Amyotrophic Lateral Sclerosis

Martin, L. J., & Chang, Q. (2011) · Molecular Neurobiology · doi:10.1007/s12035-011-8217-x · Cited by 63 · see citing works

NP001 regulation of macrophage activation markers in ALS: A phase I clinical and biomarker study

Miller, R. G., Zhang, R., Block, G. A., Katz, J., Barohn, R. J., Kasarskis, E. J., Forshew, D. A., Gopalakrishnan, V., & McGrath, M. S. (2014) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2014.951940 · Cited by 63 · see citing works

Macrophage colony stimulating factor (M-CSF) exacerbates ALS disease in a mouse model through altered responses of microglia expressing mutant superoxide dismutase

Gowing, G., Lalancette-Hébert, M., Audet, J.-N., Dequen, F., & Julien, J.-P. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.08.021 · Cited by 53 · see citing works

Stem Cell-Derived Motor Neurons: Applications and Challenges in Amyotrophic Lateral Sclerosis

Thonhoff, J. R., Ojeda, L. D., & Wu, P. (2009) · Current Stem Cell Research & Therapy · doi:10.2174/157488809789057392 · Cited by 53 · see citing works

Motor neuron–immune interactions: the vicious circle of ALS

Barbeito, A. G., Mesci, P., & Boillée, S. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0429-0 · Cited by 53 · see citing works

Experimental models for the study of neurodegeneration in amyotrophic lateral sclerosis

Tovar‐y‐Romo, L. B., Santa-Cruz, L. D., & Tapia, R. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-31 · Cited by 52 · see citing works

Increased activation ability of monocytes from ALS patients

Du, Y., Zhao, W., Thonhoff, J. R., Wang, J., Wen, S., & Appel, S. H. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113259 · Cited by 52 · see citing works

Microglia and Astrocytes in Amyotrophic Lateral Sclerosis: Disease-Associated States, Pathological Roles, and Therapeutic Potential

You, J., Youssef, M., Santos, J. R., Lee, J., & Park, J. (2023) · Biology · doi:10.3390/biology12101307 · Cited by 56 · see citing works

New insights into SMA pathogenesis: immune dysfunction and neuroinflammation

Deguise, M., & Kothary, R. (2017) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.423 · Cited by 49 · see citing works

Skeletal Muscle-Restricted Expression of Human SOD1 in Transgenic Mice Causes a Fatal ALS-Like Syndrome

Martin, L. J., & Wong, M. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.592851 · Cited by 49 · see citing works

Differentiation of Glial Cells From hiPSCs: Potential Applications in Neurological Diseases and Cell Replacement Therapy

Zheng, W., Li, Q., Zhao, C., Da, Y., Zhang, H., & Chen, Z. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00239 · Cited by 48 · see citing works

Relationship between neuropathology and disease progression in the SOD1G93A ALS mouse

Yang, W. W., Sidman, R. L., Taksir, T. V., Treleaven, C. M., Fidler, J. A., Cheng, S. H., Dodge, J. C., & Shihabuddin, L. S. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.11.019 · Cited by 47 · see citing works

Neural and glial progenitor transplantation as a neuroprotective strategy for Amyotrophic Lateral Sclerosis (ALS)

Haidet-Phillips, A. M., & Maragakis, N. J. (2015) · Brain Research · doi:10.1016/j.brainres.2015.06.035 · Cited by 47 · see citing works

Microglial overexpression of fALS-linked mutant SOD1 induces SOD1 processing impairment, activation and neurotoxicity and is counteracted by the autophagy inducer trehalose

Massenzio, F., Peña‐Altamira, E., Petralla, S., Virgili, M., Zuccheri, G., Miti, A., Polazzi, E., Mengoni, I., Piffaretti, D., & Monti, B. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.10.013 · Cited by 45 · see citing works

Opposite regulation of metabotropic glutamate receptor 3 and metabotropic glutamate receptor 5 by inflammatory stimuli in cultured microglia and astrocytes

Berger, J. V., Dumont, A. O., Focant, M. C., Vergouts, M., Sternotte, A., Calas, A.-G., Goursaud, S., & Hermans, E. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2011.12.044 · Cited by 44 · see citing works

Neuroinflammation in Amyotrophic Lateral Sclerosis: Role of Redox (dys)Regulation

D’Ambrosi, N., Cozzolino, M., & Carrı̀, M. T. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7271 · Cited by 44 · see citing works

Potential of activated microglia as a source of dysregulated extracellular microRNAs contributing to neurodegeneration in amyotrophic lateral sclerosis

Christoforidou, E., Joilin, G., & Hafezparast, M. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01822-4 · Cited by 41 · see citing works

Combined Metabolomics and Transcriptomics Approaches to Assess the IL-6 Blockade as a Therapeutic of ALS: Deleterious Alteration of Lipid Metabolism

Patin, F., Baranek, T., Vourc’h, P., Nadal‐Desbarats, L., Goossens, J., Marouillat, S., Dessein, A., Descat, A., Hounoum, B. M., Bruno, C., et al. (2016) · Neurotherapeutics · doi:10.1007/s13311-016-0461-3 · Cited by 41 · see citing works

Microglia as therapeutic targets after neurological injury: strategy for cell therapy

Scott, M. C., Bedi, S. S., Olson, S. D., Sears, C. M., & Cox, C. S. (2021) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2021.1934447 · Cited by 42 · see citing works

The Inflammatory Puzzle: Piecing together the Links between Neuroinflammation and Amyotrophic Lateral Sclerosis

He, D., Xu, Y. C., Liu, M., & Cui, L. (2023) · Aging and Disease · doi:10.14336/ad.2023.0519 · Cited by 42 · see citing works

Mutant SOD1 G93A microglia have an inflammatory phenotype and elevated production of MCP-1

Sargsyan, S. A., Blackburn, D. J., Barber, S. C., Monk, P. N., & Shaw, P. J. (2009) · Neuroreport · doi:10.1097/wnr.0b013e328331e8fa · Cited by 39 · see citing works

Sulfhydryl-mediated redox signaling in inflammation: role in neurodegenerative diseases

Miller, O. G., & Mieyal, J. J. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1496-7 · Cited by 39 · see citing works

iPSC-Derived Neural Stem Cells Act via Kinase Inhibition to Exert Neuroprotective Effects in Spinal Muscular Atrophy with Respiratory Distress Type 1

Simone, C., Nizzardo, M., Rizzo, F., Ruggieri, M., Riboldi, G. M., Salani, S., Bucchia, M., Bresolin, N., Comi, G. P., & Corti, S. P. (2014) · Stem Cell Reports · doi:10.1016/j.stemcr.2014.06.004 · Cited by 38 · see citing works

Genetic validation of a therapeutic target in a mouse model of ALS

de Boer, A. S., Koszka, K., Kiskinis, E., Suzuki, N., Davis‐Dusenbery, B. N., & Eggan, K. C. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009351 · Cited by 36 · see citing works

CCAAT/enhancer binding protein δ regulates glial proinflammatory gene expression.

Valente, T., Straccia, M., Gresa-arribas, N., Dentesano, G., Tusell, J. M., Serratosa, J., Mancera, P., Solà, C., & Saura, J. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.02.007 · Cited by 35 · see citing works

Dysregulation of IGF-1/GLP-1 signaling in the progression of ALS: potential target activators and influences on neurological dysfunctions

Shandilya, A., & Mehan, S. (2021) · Neurological Sciences · doi:10.1007/s10072-021-05328-6 · Cited by 34 · see citing works

A simplified approach for efficient isolation of functional microglial cells: Application for modeling neuroinflammatory responses in vitro

Sepulveda-Diaz, J. E., Ouidja, M. O., Socías, S. B., Hamadat, S., Guerreiro, S., Raisman‐Vozari, R., & Michel, P. P. (2016) · Glia · doi:10.1002/glia.23032 · Cited by 31 · see citing works

Protocatechuic Acid Extends Survival, Improves Motor Function, Diminishes Gliosis, and Sustains Neuromuscular Junctions in the hSOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis

Koza, L. A., Winter, A. N., Holsopple, J., Baybayon-Grandgeorge, A. N., Peña, C., Olson, J. R., Mazzarino, R. C., Patterson, D., & Linseman, D. A. (2020) · Nutrients · doi:10.3390/nu12061824 · Cited by 33 · see citing works

Partial IGF ‐1 deficiency induces brain oxidative damage and edema, which are ameliorated by replacement therapy

Puche, J. E., Muñoz, Ú., García‐Magariño, M., Sádaba, M. C., & Castilla‐Cortázar, I. (2016) · BioFactors · doi:10.1002/biof.1255 · Cited by 31 · see citing works

C/EBPβ expression in activated microglia in amyotrophic lateral sclerosis

Valente, T., Mancera, P., Tusell, J. M., Serratosa, J., & Saura, J. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.09.019 · Cited by 30 · see citing works

Bid Promotes K63-Linked Polyubiquitination of Tumor Necrosis Factor Receptor Associated Factor 6 (TRAF6) and Sensitizes to MutantSOD1-Induced Proinflammatory Signaling in Microglia

Kinsella, S. M., König, H., & Prehn, J. H. M. (2016) · eNeuro · doi:10.1523/eneuro.0099-15.2016 · Cited by 30 · see citing works

Phenotypic heterogeneity of astrocytes in motor neuron disease

Trías, E., Barbeito, L., & Yamanaka, K. (2018) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12476 · Cited by 31 · see citing works

Microglia in ALS: Insights into Mechanisms and Therapeutic Potential

Bond, S., Saxena, S., & Sierra-Delgado, J. A. (2025) · Cells · doi:10.3390/cells14060421 · Cited by 32 · see citing works

G-CSF protects motoneurons against axotomy-induced apoptotic death in neonatal mice

Henriques, A., Pitzer, C., Dupuis, L., & Schneider, A. (2010) · BMC Neuroscience · doi:10.1186/1471-2202-11-25 · Cited by 28 · see citing works

Review: Microglia in motor neuron disease

Ashford, B., Boche, D., Cooper‐Knock, J., Heath, P. R., Simpson, J. E., & Highley, J. R. (2020) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12640 · Cited by 27 · see citing works

Neurotoxic Species of Misfolded SOD1G93ARecognized by Antibodies Against the P2X4Subunit of the ATP Receptor Accumulate in Damaged Neurons of Transgenic Animal Models of Amyotrophic Lateral Sclerosis

Hernández, S., Casanovas, A., Piedrafita, L., Tarabal, O., & Esquerda, J. E. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181cd3e33 · Cited by 27 · see citing works

Transient middle cerebral artery occlusion induces microglial priming in the lumbar spinal cord: a novel model of neuroinflammation

Moisse, K., Welch, I. D., Hill, T. L., Volkening, K., & Strong, M. J. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-29 · Cited by 27 · see citing works

Neuroinflammation and Amyotrophic Lateral Sclerosis: Recent Advances in Anti-Inflammatory Cytokines as Therapeutic Strategies

Stacchiotti, C., di Regnella, S. M., Cinotti, M., Spalloni, A., & Volpe, E. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26083854 · Cited by 28 · see citing works

Reduction of cytosolic phospholipase A2α upregulation delays the onset of symptoms in SOD1G93A mouse model of amyotrophic lateral sclerosis

Solomonov, Y., Hadad, N., & Lévy, R. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0602-y · Cited by 26 · see citing works

Accumulation of misfolded SOD1 outlines distinct patterns of motor neuron pathology and death during disease progression in a SOD1G93A mouse model of amyotrophic lateral sclerosis

Salvany, S., Casanovas, A., Piedrafita, L., Gras, S., Calderó, J., & Esquerda, J. E. (2022) · Brain Pathology · doi:10.1111/bpa.13078 · Cited by 25 · see citing works

Extracellular mutant SOD1 induces microglial‐mediated motoneuron injury

Zhao, W., Beers, D. R., Henkel, J. S., Zhang, W., Urushitani, M., Julien, J., & Appel, S. H. (2010) · Glia · doi:10.1002/glia.20919 · Cited by 288 · see citing works

Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis

Beers, D. R., Henkel, J. S., Xiao, Q., Zhao, W., Wang, J., Yen, A. A., Siklos, L., McKercher, S. R., & Appel, S. H. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607423103 · Cited by 733 · see citing works

Increased cytotoxic potential of microglia from ALS‐transgenic mice

Weydt, P., Yuen, E., Ransom, B. R., & Möller, T. (2004) · Glia · doi:10.1002/glia.20062 · Cited by 147 · see citing works

Expression of Amyotrophic Lateral Sclerosis-linked SOD1 Mutant Increases the Neurotoxic Potential of Microglia via TLR2

Liu, Y., Hao, W., Dawson, A., Liu, S., & Fassbender, K. C. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804446200 · Cited by 117 · see citing works

Inflammatory cytokines increase mitochondrial damage in motoneuronal cells expressing mutant SOD1

Ferri, A., Nencini, M., Cozzolino, M., Carrara, P., Moreno, S., & Carrı̀, M. T. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.08.004 · Cited by 17 · see citing works